Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$130.86 - $143.19 $12,824 - $14,032
-98 Reduced 5.49%
1,687 $232,000
Q1 2024

May 15, 2024

BUY
$130.4 - $143.74 $3,129 - $3,449
24 Added 1.36%
1,785 $246,000
Q4 2023

Feb 14, 2024

SELL
$106.07 - $132.76 $11,879 - $14,869
-112 Reduced 5.98%
1,761 $232,000
Q3 2023

Nov 14, 2023

BUY
$94.02 - $117.1 $176,099 - $219,328
1,873 New
1,873 $210,000
Q4 2022

Feb 14, 2023

BUY
$106.72 - $127.06 $196,471 - $233,917
1,841 New
1,841 $219,000
Q4 2021

Feb 14, 2022

SELL
$79.65 - $106.22 $171,645 - $228,904
-2,155 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$86.18 - $99.03 $10,600 - $12,180
-123 Reduced 5.4%
2,155 $207,000
Q2 2021

Aug 16, 2021

SELL
$89.43 - $102.27 $1,788 - $2,045
-20 Reduced 0.87%
2,278 $222,000
Q1 2021

May 14, 2021

BUY
$87.57 - $119.4 $201,235 - $274,381
2,298 New
2,298 $224,000
Q4 2020

Feb 11, 2021

SELL
$86.91 - $108.33 $3,041 - $3,791
-35 Closed
0 $0
Q3 2020

Dec 16, 2020

SELL
$96.16 - $135.15 $204,724 - $287,734
-2,129 Reduced 98.38%
35 $3,000
Q3 2020

Dec 16, 2020

SELL
$96.16 - $135.15 $3,365 - $4,730
-35 Reduced 1.59%
2,164 $208,000
Q3 2020

Nov 13, 2020

BUY
$96.16 - $135.15 $35,098 - $49,329
365 Added 19.9%
2,199 $211,000
Q2 2020

Aug 14, 2020

BUY
$85.09 - $130.36 $156,055 - $239,080
1,834 New
1,834 $223,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12.2B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Wetherby Asset Management Inc Portfolio

Follow Wetherby Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.